title: Update in chronic obstructive pulmonary disease 2006.
authors.affiliation: Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Klaus F
authors.initials: KF
authors.lastname: Rabe
authors.forename: Bianca
authors.initials: B
authors.lastname: Beghé
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Luppi
authors.forename: Leonardo M
authors.initials: LM
authors.lastname: Fabbri
mesh_terms: D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003952:Diagnostic Imaging; D000068298:Fluticasone; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D018482:Muscle, Skeletal / Q000503:physiopathology; D010102:Oxygen Inhalation Therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D012132:Respiratory Muscles / Q000503:physiopathology; D000068299:Salmeterol Xinafoate; D016540:Smoking Cessation
chemical_list: D000730:Androstadienes; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol